Cocaine receptors labeled by [3H]2 beta-carbomethoxy-3 beta-(4- fluorophenyl)tropane

BK Madras, RD Spealman, MA Fahey, JL Neumeyer, JK Saha and RA Milius

Harvard Medical School, New England Regional Primate Research Center, Southborough, Massachusetts 01772.

The potent cocaine analog 2 beta-carbomethoxy-3 beta-(4-fluorophenyl)- tropane (CFT, also designated WIN 35,428) was tritiated and evaluated as a molecular probe for cocaine receptors in caudate putamen membranes of cynomolgus monkeys. Kinetic, saturation, and competition experiments indicated that [3H]CFT, like [3H]cocaine, bound to at least two components. Association and dissociation of the radioligand at 0-4 degrees occurred in two phases; the t 1/2 for dissociation of the fast and slow components was 2.5 and 23 min, respectively. Saturation analysis revealed high and low affinity binding components with affinities (Kd) of 4.7 +/- 1.2 and 60 +/- 12 nM (means +/- SE) and densities (Bmax) of 50 +/- 18 and 290 +/- 20 pmol/g of tissue, respectively. [3H]CFT was displaced stereoselectively by the enantiomers of cocaine and by the diastereoisomers of the phenyltropane analog of cocaine. Most congeners displaced [3H]CFT fully, with shallow competition curves (nH, 0.69-0.81). In contrast, several monoamine uptake inhibitors structurally unrelated to cocaine (GBR 12909, Lu 19- 005, and mazindol) displaced a maximum of about 90% specifically bound [3H]CFT, with steeper competition curves (nH, 0.89-1.3), suggesting that these drugs bind to a subpopulation of [3H]CFT-labeled sites. The rank order of potency observed in the present study is identical to the rank order of potency at binding sites labeled by [3H]cocaine: Lu 19- 005 greater than mazindol greater than CFT greater than GBR 12909 greater than (-)-cocaine greater than bupropion greater than WIN 35,140 greater than (+)-cocaine. Moreover, there is a high positive correlation (r, 0.99, p less than 0.001) between the affinities of drugs at sites labeled by [3H]CFT and [3H]cocaine. The results show that [3H]CFT and [3H]cocaine bind to a similar spectrum of sites in monkey caudate putamen. Because of its higher affinity and slower dissociation rate, [3H]CFT appears to be a superior radioligand probe for these sites.

Volume 36, Issue 4, pp. 518-524, 10/01/1989
Copyright © 1989 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				B. K. Madras, M. A. Fahey, M. Goulet, Z. Lin, J. Bendor, C. Goodrich, P. C. Meltzer, D. R. Elmaleh, E. Livni, A. A. Bonab, et al. Dopamine Transporter (DAT) Inhibitors Alleviate Specific Parkinsonian Deficits in Monkeys: Association with DAT Occupancy in Vivo J. Pharmacol. Exp. Ther., November 1, 2006; 319(2): 570 - 585. [Abstract] [Full Text] [PDF]

				G. A. Ricaurte, A. O. Mechan, J. Yuan, G. Hatzidimitriou, T. Xie, A. H. Mayne, and U. D. McCann Amphetamine Treatment Similar to That Used in the Treatment of Adult Attention-Deficit/Hyperactivity Disorder Damages Dopaminergic Nerve Endings in the Striatum of Adult Nonhuman Primates J. Pharmacol. Exp. Ther., October 1, 2005; 315(1): 91 - 98. [Abstract] [Full Text] [PDF]

				D. C. Mash, Q. Ouyang, J. Pablo, M. Basile, S. Izenwasser, A. Lieberman, and R. J. Perrin Cocaine Abusers Have an Overexpression of alpha -Synuclein in Dopamine Neurons J. Neurosci., April 1, 2003; 23(7): 2564 - 2571. [Abstract] [Full Text] [PDF]

				K. Y. Little, L. W. Elmer, H. Zhong, J. O. Scheys, and L. Zhang Cocaine Induction of Dopamine Transporter Trafficking to the Plasma Membrane Mol. Pharmacol., February 1, 2002; 61(2): 436 - 445. [Abstract] [Full Text] [PDF]

				R. A. Vaughan, J. D. Gaffaney, J. R. Lever, M. E. A. Reith, and A. K. Dutta Dual Incorporation of Photoaffinity Ligands on Dopamine Transporters Implicates Proximity of Labeled Domains Mol. Pharmacol., April 16, 2001; 59(5): 1157 - 1164. [Abstract] [Full Text]

				R. G. W. Staal, K. A. Hogan, C.-L. Liang, D. C. German, and P. K. Sonsalla In Vitro Studies of Striatal Vesicles Containing the Vesicular Monoamine Transporter (VMAT2): Rat versus Mouse Differences in Sequestration of 1-Methyl-4-phenylpyridinium J. Pharmacol. Exp. Ther., May 1, 2000; 293(2): 329 - 335. [Abstract] [Full Text]

				S. R. Letchworth, H. R. Smith, L. J. Porrino, B. A. Bennett, H. M. L. Davies, T. Sexton, and S. R. Childers Characterization of a Tropane Radioligand, [3H]2beta -Propanoyl-3beta -(4-tolyl) Tropane ([3H]PTT), for Dopamine Transport Sites in Rat Brain J. Pharmacol. Exp. Ther., May 1, 2000; 293(2): 686 - 696. [Abstract] [Full Text]

				M. A. Hebert, G. A. Larson, N. R. Zahniser, and G. A. Gerhardt Age-Related Reductions in [3H]WIN 35,428 Binding to the Dopamine Transporter in Nigrostriatal and Mesolimbic Brain Regions of the Fischer 344 Rat J. Pharmacol. Exp. Ther., March 1, 1999; 288(3): 1334 - 1339. [Abstract] [Full Text]

				K. Y. Little, L. Zhang, T. Desmond, K. A. Frey, G. W. Dalack, and B. J. Cassin Striatal Dopaminergic Abnormalities in Human Cocaine Users Am J Psychiatry, February 1, 1999; 156(2): 238 - 245. [Abstract] [Full Text]

				L. P. Shearman, A. M. McReynolds, F. C. Zhou, and J. S. Meyer Relationship between [125I]RTI-55-labeled cocaine binding sites and the serotonin transporter in rat placenta Am J Physiol Cell Physiol, December 1, 1998; 275(6): C1621 - C1629. [Abstract] [Full Text] [PDF]

				U. D. McCann, D. F. Wong, F. Yokoi, V. Villemagne, R. F. Dannals, and G. A. Ricaurte Reduced Striatal Dopamine Transporter Density in Abstinent Methamphetamine and Methcathinone Users: Evidence from Positron Emission Tomography Studies with [11C]WIN-35,428 J. Neurosci., October 15, 1998; 18(20): 8417 - 8422. [Abstract] [Full Text] [PDF]

				V. Villemagne, J. Yuan, D. F. Wong, R. F. Dannals, G. Hatzidimitriou, W. B. Mathews, H. T. Ravert, J. Musachio, U. D. McCann, and G. A. Ricaurte Brain Dopamine Neurotoxicity in Baboons Treated with Doses of Methamphetamine Comparable to Those Recreationally Abused by Humans: Evidence from [11C]WIN-35,428 Positron Emission Tomography Studies and Direct In Vitro Determinations J. Neurosci., January 1, 1998; 18(1): 419 - 427. [Abstract] [Full Text] [PDF]

				C. Xu and M. E. A. Reith WIN 35,428 and Mazindol Are Mutually Exclusive in Binding to the Cloned Human Dopamine Transporter J. Pharmacol. Exp. Ther., August 1, 1997; 282(2): 920 - 927. [Abstract] [Full Text]

				R. A. Vaughan and M. J. Kuhar Dopamine Transporter Ligand Binding Domains. STRUCTURAL AND FUNCTIONAL PROPERTIES REVEALED BY LIMITED PROTEOLYSIS J. Biol. Chem., August 30, 1996; 271(35): 21672 - 21680. [Abstract] [Full Text] [PDF]

				F. J.S. Lee, Z. B. Pristupa, B. J. Ciliax, A. I. Levey, and H. B. Niznik The Dopamine Transporter Carboxyl-terminal Tail. TRUNCATION/SUBSTITUTION MUTANTS SELECTIVELY CONFER HIGH AFFINITY DOPAMINE UPTAKE WHILE ATTENUATING RECOGNITION OF THE LIGAND BINDING DOMAIN J. Biol. Chem., August 23, 1996; 271(34): 20885 - 20894. [Abstract] [Full Text] [PDF]

				S. G. Amara Monoamine Transporters: Basic Biology with Clinical Implications Neuroscientist, September 1, 1995; 1(5): 259 - 267. [Abstract] [PDF]

				S Shimada, S Kitayama, C. Lin, A Patel, E Nanthakumar, P Gregor, M Kuhar, and G Uhl Cloning and expression of a cocaine-sensitive dopamine transporter complementary DNA Science, October 25, 1991; 254(5031): 576 - 578. [Abstract] [PDF]

				J. M. McIntosh, G. O. Corpuz, R. T. Layer, J. E. Garrett, J. D. Wagstaff, G. Bulaj, A. Vyazovkina, D. Yoshikami, L. J. Cruz, and B. M. Olivera Isolation and Characterization of a Novel Conus Peptide with Apparent Antinociceptive Activity J. Biol. Chem., October 13, 2000; 275(42): 32391 - 32397. [Abstract] [Full Text] [PDF]

				M. E. A. Reith, J. L. Berfield, L. C. Wang, J. V. Ferrer, and J. A. Javitch The Uptake Inhibitors Cocaine and Benztropine Differentially Alter the Conformation of the Human Dopamine Transporter J. Biol. Chem., July 27, 2001; 276(31): 29012 - 29018. [Abstract] [Full Text] [PDF]